← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Invizyne Technologies, Inc.
Monrovia, CA
$2,732,006
Total funding
4
Grants
Funding over time
peak $718.8K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,732,006 · 4
By mechanism
R44$2,054,674 · 1
R43$677,332 · 3
Investigators at Invizyne Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$649,993
R44 · FY2021 · AT
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$647,005
R44 · FY2022 · AT
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$631,174
R44 · FY2023 · AT
Bio-Click: A cell-free high-throughput platform for the engineering of enzymatic group transfer reactions$283,805
R43 · FY2025 · GM
GlyCoSAM: Glycolysis coupled S-adenosyl methionine regeneration for cell-free methylation reactions$243,527
R43 · FY2024 · GM
SimplePath: A Cell-free Enzymatic Platform for Cannabinoid Boisynthesis$150,000
R43 · FY2020 · GM
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$71,828
R44 · FY2022 · AT
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$47,840
R44 · FY2023 · AT
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$6,834
R44 · FY2023 · AT